BANFF, CANADA

We are thrilled to invite you to the 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology.  Taking place in Banff, Canada, from September 15-18, we look forward to welcoming you to the Banff Centre for Arts and Creativity.

Our program begins with a pre-congress symposium focused on New Frontiers in Clinical Toxicology.  In today’s environment, the toxic drug supply constitutes a public health crisis.  We will be exploring topics that bring that crisis to light such as wastewater testing (mirroring that which was in place for Covid19 testing); the use of artificial intelligence to help predict and test for novel psychoactive substances that may contribute to the toxic drug supply; we will discover what we can learn from a drug checking service and how that can inform clinical toxicology testing; and we will explore the proliferation of the semi-synthetic cannabinoids.  Cannabis has been used for thousands of years and is not a new substance, but we will look at the health impacts of cannabis legalization.  Whether you are directly involved in clinical toxicology or not, this pre-congress symposium is of significance from a public health perspective.

We will have a vibrant exhibit hall for you to explore, meet industry partners, and enjoy the stunning mountain views of the Banff Centre grounds.  Our plenary speakers will offer insights into their respective fields as we explore precision medicine in cancer treatment, the use of psychedelics in psychiatry and health issues of first nations peoples.  The Scientific Committee chairs have been working on your behalf to put together symposia that will dive into cutting-edge topics, offering a comprehensive look at the latest advancements in the field.  Engage with your colleagues at one or two breakfast roundtables and discuss a topic of mutual interest.

Sincerely,

Penny Colbourne and David Kinniburgh
Co-Chairs Banff 2024; On behalf of the Organizing Committee